130 related articles for article (PubMed ID: 11413357)
1. Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.
Burggraaf J; Westendorp RG; in't Veen JC; Schoemaker RC; Sterk PJ; Cohen AF; Blauw GJ
Thorax; 2001 Jul; 56(7):567-9. PubMed ID: 11413357
[TBL] [Abstract][Full Text] [Related]
2. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27.
Lee DK; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jan; 57(1):100-4. PubMed ID: 14678347
[TBL] [Abstract][Full Text] [Related]
3. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
Papi A; Canonica GW; Maestrelli P; Paggiaro P; Olivieri D; Pozzi E; Crimi N; Vignola AM; Morelli P; Nicolini G; Fabbri LM;
N Engl J Med; 2007 May; 356(20):2040-52. PubMed ID: 17507703
[TBL] [Abstract][Full Text] [Related]
4. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
5. Effects of airway calibre on lung delivery of nebulised salbutamol.
Lipworth BJ; Clark DJ
Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
[TBL] [Abstract][Full Text] [Related]
6. Short-term lower leg growth in asthmatic children treated with inhaled beta2-agonists.
Plomgaard AM; Schou AJ; Wolthers OD
Ann Hum Biol; 2006; 33(2):135-41. PubMed ID: 16684688
[TBL] [Abstract][Full Text] [Related]
7. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
[TBL] [Abstract][Full Text] [Related]
8. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
9. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of salbutamol on systemic vascular function in people with asthma.
Moore LE; Kapoor K; Byers BW; Brotto AR; Ghods-Esfahani D; Henry SL; St James RB; Stickland MK
Respir Med; 2019 Aug; 155():133-140. PubMed ID: 31349187
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic responses to salbutamol and isometric exercise are altered in young adults with mild asthma.
Waring WS; Leigh RB
Eur J Clin Pharmacol; 2005 Mar; 61(1):9-14. PubMed ID: 15785958
[TBL] [Abstract][Full Text] [Related]
12. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
13. [The evaluation of efficacy and tolerability of salbutamol administered by nebulization in patients with stable severe bronchial asthma].
Kroczyńska-Bednarek J; Kwiatkowska S; Zagdańska R; Zieba M; Tymińska K; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2001; 69(1-2):84-92. PubMed ID: 11475562
[TBL] [Abstract][Full Text] [Related]
14. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.
Fishwick D; Bradshaw L; Macdonald C; Beasley R; Gash D; Bengtsson T; Bondesson E; Borgström L
Am J Respir Crit Care Med; 2001 Feb; 163(2):474-7. PubMed ID: 11179125
[TBL] [Abstract][Full Text] [Related]
15. Cilomilast (Ariflo) does not potentiate the cardiovascular effects of inhaled salbutamol.
Murdoch RD; Cowley H; Kelly J; Higgins R; Webber D
Pulm Pharmacol Ther; 2002; 15(6):521-7. PubMed ID: 12493339
[TBL] [Abstract][Full Text] [Related]
16. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
Lipworth BJ; Struthers AD; McDevitt DG
Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
[TBL] [Abstract][Full Text] [Related]
17. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
Ullman A; Svedmyr N
Thorax; 1988 Sep; 43(9):674-8. PubMed ID: 2904183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
